Pharming Group NV (PHAR)
$8.04 -$0.41 (-4.90%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$575.93M -
Day's Range
$8.04 - $8.16 -
Volume
6,719 -
52 Week Low / High
$6.65 - $13.20 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $0.00
- Target Price
Company News
-
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib — Nov 21st, 2023
Pharming Group N.V. The multinational Phase III study is evaluating a new pediatric granulated formulation of leniolisib in children aged 1 to 6 years with APDS, a rare primary immunodeficiency Leiden, The Netherlands, November 21, 2023: Pharming Group N.V. (“Pharming” or “the Comp...
-
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib — Nov 21st, 2023
The multinational Phase III study is evaluating a new pediatric granulated formulation of leniolisib in children aged 1 to 6 years with APDS, a rare primary immunodeficiency Leiden, The Netherlands, November 21, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Ams...
Similar Stocks
Portfolio
Comprised of 1 portfolios